Dermatofibrosarcoma protuberans: a partial response to imatinib therapy

Dermatol Surg. 2006 Mar;32(3):456-9. doi: 10.1111/j.1524-4725.2006.32090.x.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Cheek
  • Dermatofibrosarcoma / drug therapy*
  • Dermatofibrosarcoma / pathology
  • Dermatofibrosarcoma / surgery
  • Facial Neoplasms / drug therapy*
  • Facial Neoplasms / pathology
  • Facial Neoplasms / surgery
  • Humans
  • Imatinib Mesylate
  • Male
  • Middle Aged
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / surgery

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate